Background
==========

Keratitis is a condition in which the cornea becomes inflamed. Keratitis is the second most common cause of legal blindness worldwide, after cataracts \[[@b1-medscimonit-26-e922710]\]. Approximately 12.2% of all corneal transplantations are performed as the result of active infectious keratitis \[[@b2-medscimonit-26-e922710]\]. The prevalence of corneal diseases is 0.8%, whereas the prevalence of infectious keratitis is 0.15% \[[@b3-medscimonit-26-e922710]\]. The American National Ambulatory Care and Emergency Department databases show that episodes of keratitis and contact lens-related disorders cost about \$175 million annually in direct healthcare expenditures \[[@b4-medscimonit-26-e922710]\], and that office and outpatient clinic visits require over 250 000 hours of clinician time annually \[[@b4-medscimonit-26-e922710]\].

Keratitis can arise from noninfectious causes (e.g., autoimmune and aseptic inflammation) or infectious agents (e.g., microbes such as bacteria, fungi, amebae, and viruses) \[[@b4-medscimonit-26-e922710],[@b5-medscimonit-26-e922710]\]. Multiple genes have been identified as the basis for noninfectious keratitis. Autosomal dominant keratitis (ADK) is associated with the *PAX6* gene \[[@b6-medscimonit-26-e922710]\]. Mutations in *PAX6* were shown to underlie ADK when significant linkage was detected in both the *PAX6* region and ADK in 15 affected members in a single family \[[@b6-medscimonit-26-e922710]\]. Keratitis is one of the characteristics of tyrosinemia type II, which is an autosomal recessive disease \[[@b7-medscimonit-26-e922710]\]. Keratitis-ichthyosis-deafness (KID) syndrome is also characterized by vascularizing keratitis, and is caused by heterozygous mis-sense mutations in the connexin-26 gene, *GJB2* \[[@b8-medscimonit-26-e922710]\]. Induction of permanent connexin-26 mutation expression can result in progressive keratitis in KID syndrome \[[@b8-medscimonit-26-e922710]\].

Genetics plays a role in infectious keratitis, from various types of infections and epithelial defects, as reported previously \[[@b9-medscimonit-26-e922710]\]. Even though commonly exposed to these pathogens in daily life, not everyone who contacts them is infected, perhaps because of differences in genetic susceptibility to infections. Multiple miRNAs, expressed on the ocular surface, function to regulate immunity on the ocular surface \[[@b10-medscimonit-26-e922710]\]. Resistance to *Pseudomonas aeruginosa* infection was higher in miR-183/96/182 cluster knockdown mice compared to wild-type mice \[[@b11-medscimonit-26-e922710],[@b12-medscimonit-26-e922710]\] and the upregulation of miR-155 was reported to increase corneal susceptibility to *P. aeruginosa* \[[@b13-medscimonit-26-e922710]\]. Furthermore, a relationship between recurrent herpes simplex keratitis and host gene polymorphisms has been proposed \[[@b14-medscimonit-26-e922710]\].

Numerous alleles, isolated in many *loci*, lead to complex disease susceptibility through the contributions of common and rare alleles \[[@b15-medscimonit-26-e922710]\]. There has not yet been a description of the genetic risk factors for keratitis on a genome-wide scale, so there are still many keratitis candidate genes to be identified.

Because of the existence of allelic heterogeneity, genetic association analysis and the statistical power of gene-based association tests are improved through integrating diverse single-nucleotide polymorphisms (SNPs) into a single statistic \[[@b16-medscimonit-26-e922710],[@b17-medscimonit-26-e922710]\]. Gene-based analysis using the versatile gene-based association study (VEGAS) approach, is widely used in modern genome-wide association studies. In the present study, a genome-wide association study of keratitis was performed using the large-scale UK Biobank (UKB) cohort. Both SNP-based and gene-based analyses were performed, and functional investigations of the identified genes were conducted.

Material and Methods
====================

Ethics statement
----------------

This study was conducted in accordance with the Helsinki Declaration II and was approved by the Ethics Committee of First Affiliated Hospital of Soochow University.

Subjects
--------

The sample consisted of 337 199 white participants of European ancestry from the UKB, including 239 cases and 336 960 controls. The diagnosis of keratitis was coded according to the World Health Organization's International Classification of Diseases (ICD) and Related Health Problems.

Quality control
---------------

This study had strict quality control (QC). Duplicate SNPs or SNPs deviating from Hardy-Weinberg equilibrium (*p*\<10^−6^) or SNPs including a minor allele frequency (MAF) \<0.01 or imputation r^2^ \<0.4 were excluded.

SNP-based analysis and enrichment analysis
------------------------------------------

The SNP-based association analysis was performed by Dr. Benjamin Neale's lab, and the summary results were generously made publicly available. The SNP association results were downloaded from the web link (*<http://www.nealelab.is/uk-biobank>*).

Fifty-two genomic features are available from a study by Finucane \[[@b18-medscimonit-26-e922710]\], including 3′- and 5′-untranslated regions (UTR). Every SNP was annotated into at least 1 genomic feature. A set of credible risk variants (CRVs) in each novel identified locus was identified. We selected the variants which were located in 500 kb around the lead SNPs and with p values within 2 orders of magnitude of the lead SNPs \[[@b19-medscimonit-26-e922710]\]. The enrichment of CRV in each genomic feature was then examined using the method described in Pei et al. \[[@b20-medscimonit-26-e922710]\]. Specifically, 100 1-Mb control regions were randomly sampled across the genome so that the distance between any identified region was at least 1 Mb. A logistic regression model was utilized to examine the association of each feature, with the dependent variable of the status of being CRVs and the independent variable of the status with the feature. The model was adjusted for the dependence due to linkage disequilibrium (LD) within each region using robust variance estimation, clustering on region, using the R package "multiwayvcov".

Gene-based analyses using VEGAS
-------------------------------

With the SNP-based genome-wide association statistics, a gene-based association analysis was performed with VEGAS \[[@b21-medscimonit-26-e922710]\]. P values of diverse SNPs in a gene region were combined into a gene-based score. Then, permutation-based testing, which simulated genotype data from a multivariate normal distribution, was used to account for LD. VEGAS has efficient computing power, considering the number of permutation simulations is adaptive. Individual SNP p values and information of LD structure were required as input by VEGAS \[[@b21-medscimonit-26-e922710]\].

Candidate gene prioritization
-----------------------------

To prioritize potential candidate genes from SNP-based association results, 5 data sources were used to find the causality of a gene: i) genes nearest to the lead CRV (N); ii) genes including a mis-sense coding CRV (M); iii) genes related to 1 or more CRVs on the level of mRNA (cis-eQTL, Q); iv) genes having biological function with keratitis (B); and v) genes prioritized by summary data-based Mendelian randomization method (SMR) analysis (S).

Cis-eQTL was calculated by the GTEx (v7) project and obtained from the GTEx web portal (*[www.gtexportal.org/](www.gtexportal.org/)*). SMR analysis is a kind of prioritization analysis integrating summary data from genome-wide association studies (GWAS). SMR analysis was performed to identify the correlation between the expression levels of genes and the trait due to pleiotropy effects or causality \[[@b22-medscimonit-26-e922710]\].

Module analysis
---------------

We used Cytoscape (version 3.6.1) bioinformatics software to analyze and visualize molecular interaction networks of identified hub genes \[[@b23-medscimonit-26-e922710]\]. Molecular Complex Detection (MCODE) (version 1.5.1), a plug-in of Cytoscape, was utilized to find densely connected regions with clustering in a given network according to topology \[[@b24-medscimonit-26-e922710]\]. MCODE was used to detect the most significant and densest module in the protein-protein interaction (PPI) network based on the following criteria: K-score=2, degree cut-off=4, max depth=100 and node score cut-off=0.20.

PPI network construction
------------------------

The online database Search Tool for the Retrieval of Interacting Genes (STRING; version 10.0) was used to find the PPI network of the hub genes and to further analyze the functional interactions among proteins (*<http://string-db.org>*) \[[@b25-medscimonit-26-e922710]\], which elucidated the initiation or development mechanisms in keratitis. Confidence scores of interactions greater than 0.15 were regarded as statistically significant.

Functional enrichment analysis
------------------------------

Recognizing the roles of the hub genes in keratitis, Gene Ontology (GO) enrichment analysis, including biological processes (BP), cellular components (CC), and molecular functions (MF), were analyzed \[[@b26-medscimonit-26-e922710]\]. The online Database for Annotation, Visualization, and Integrated Discovery (DAVID; Version 6.8) was used to detect the function of development-related signaling pathways in keratitis (*<http://david.ncifcrf.gov>*) \[[@b27-medscimonit-26-e922710]\]. P values smaller than 0.05 were regarded as statistically significant. A bubble chart was used to illustrate GO enrichment.

Transcription factor network construction
-----------------------------------------

A transcription factor network was constructed in the 2 genes (*IQCF3* and *SOD3*) using R software (Version 3.3.2). In line with hub genes, significant nodes were marked in red.

Results
=======

This study consisted of 3 stages. In the first stage, a total of 34 SNPs from 14 distinct *loci* were identified from UKB, the enrichment of the variants at these newly identified *loci* was assessed in terms of diverse genomic features, and candidate genes were then prioritized. In the second stage, *IQCF3* and *SOD3* were identified by their p values through gene-based tests on the basis of individual SNP-based tests. In the third stage, 33 hub genes were selected, functional annotation of these hub genes was performed, and transcriptional factors of *IQCF3* and *SOD3* were predicted.

SNP-based analyses
------------------

After filtering, a total of 7 601 143 SNPs remained for subsequent analyses. A logarithmic quantile-quantile (QQ) plot of SNP-based association results is shown in [Figure 1A](#f1-medscimonit-26-e922710){ref-type="fig"}. The obvious deviation in the tail of the distribution indicated true association signals. Additionally, a Manhattan plot of SNP-based associations is shown in [Figure 1B](#f1-medscimonit-26-e922710){ref-type="fig"}. At the genome-wide significance level (α=5.0×10^−8^), a total of 34 SNPs from 14 distinct *loci* were identified. [Table 1](#t1-medscimonit-26-e922710){ref-type="table"} lists the major results of the novel identified *loci*.

The enrichment of the variants at the novel *loci* was assessed for diverse genomic features. A set of CRVs was identified as SNPs with p values within 2 orders of magnitude of the lead SNP at each locus. Ninety-five CRVs were identified in this study. Then, the enrichment of these CRVs was evaluated for 52 genomic features, including transcription factor binding sites (TFBSs), transcription start sites (TSSs), 5′-untranslated regions (5′-UTRs) and 3′-UTRs, promoters, and histone mark active regions. At the level of Bonferroni-corrected significance (α=9.62×10^−4^), CRVs were significantly enriched in 8 features: FANTOM5 enhancers (p=5.00×10^−117^), 5′-UTRs (p=2.13×10^−109^), conserved regions (p=1.17×10^−85^), TSSs (p=3.10×10^−73^), repressed regions (p=4.41×10^−6^), TFBSs (p=5.26×10^−4^), enhancers (p=6.55×10^−4^), and introns (p=9.37×10^−4^).

Gene-based analyses
-------------------

Gene-based tests were performed using VEGAS software on the basis of individual SNP-based tests. The gene-based association tests involved 23 779 genes. Bonferroni correction was utilized to determine the genome-wide significance level (GWAS, 0.05/23,779=2.10×10^−6^). [Figure 2A and 2B](#f2-medscimonit-26-e922710){ref-type="fig"} illustrate the QQ plot and Manhattan plot of the gene-based association tests, respectively. The marked deviation in the tail of the distribution in [Figure 2A](#f2-medscimonit-26-e922710){ref-type="fig"} demonstrates a genuine connection between the genes and keratitis.

[Table 2](#t2-medscimonit-26-e922710){ref-type="table"} shows that *IQCF3* and *SOD3* were identified according to their p values from the VEGAS analysis (p\<2.50×10^−6^). This study investigated whether allelic heterogeneity existed in the identified novel genes by studying SNP-level LD structure within each gene. The regional LD structure and association signals of the 2 novel genes are shown in [Figure 3](#f3-medscimonit-26-e922710){ref-type="fig"}. The 42 SNPs in the *IQCF3* gene clustered into a single haplotype block ([Figure 3A](#f3-medscimonit-26-e922710){ref-type="fig"}). The 71 SNPs in *SOD3* clustered into 2 haplotype blocks ([Figure 3B](#f3-medscimonit-26-e922710){ref-type="fig"}), but the significant SNP association signals were only present in the larger block. Thus, the association signals of both novel genes might arise from a single source.

To prioritize candidate genes from the SNP-based association results, 5 data sources for CRV annotation were incorporated to explore causality: i) the genes nearest to the lead CRV (N); ii) the genes including a mis-sense coding CRV (M); iii) the genes related to 1 or more CRVs at the level of mRNA (cis-eQTL, Q); iv) the genes having biological function with keratitis (B); and v) the genes prioritized by SMR analysis (S). With these strategies, 32 candidate genes were prioritized within these 14 new *loci* ([Table 3](#t3-medscimonit-26-e922710){ref-type="table"}). More than one kind of supporting evidence was found for some of these genes. For example, *CX3CR1* at 3p22.2 contained a mis-sense coding CRV of the lead CRV rs9861402 within this locus. *CX3CR1* was also prioritized due to biological function with keratitis and being the nearest to the lead CRV.

Hub-gene selection and analyses
-------------------------------

As described above, *IQCF3* and *SOD3* were identified based on their p values found in gene-based analysis. In addition, 32 genes were seriously considered as candidate genes related to keratitis through candidate gene prioritization. Remarkably, *IQCF3* was identified by both analyses. In conclusion, a total of 33 hub genes were selected through these 2 analyses.

This study assessed the PPI networks among 33 hub genes. A network among the hub genes and their co-expressed genes was constructed visually ([Figure 4A](#f4-medscimonit-26-e922710){ref-type="fig"}). After statistical selection, *SOD3*, *MGP*, *VARS2*, *RPL14*, *HIST4H4*, and *CSNK1G2* were considered to be densely connected nodes in the PPI network. Functional enrichment analyses of hub genes were performed in bubble charts by DAVID ([Figure 4B](#f4-medscimonit-26-e922710){ref-type="fig"}). Through functional analyses of the 33 hub genes, enrichment profiles indicated that the hub genes were mainly enriched in the extracellular exosome, calmodulin binding, and extracellular matrix ([Supplementary Table 1](#s1-medscimonit-26-e922710){ref-type="supplementary-material"}). GO analysis suggested that changes in the cellular components of the hub genes were significantly enriched in the extracellular exosome and extracellular matrix. Changes in molecular function of the hub genes were mostly enriched in calmodulin binding.

Transcription factor network construction
-----------------------------------------

The transcription factor network was predicted for the 2 genes (*IQCF3* and *SOD3*), as shown in [Figure 5](#f5-medscimonit-26-e922710){ref-type="fig"}. In connection with these 2 hub genes, significant nodes are marked in red.

Discussion
==========

A total of 34 SNPs from 14 distinct *loci* were identified as associated with keratitis in samples from the UKB. In addition, *IQCF3* and *SOD3* were identified by their p values through gene-based tests on the basis of individual SNP-based tests. Thirty-two candidate genes were then prioritized using multiple sources of information. Four of these candidate genes (*CX3CR1*, *SEC62*, *HLA-B*, and *MUC21*) were found to be closely associated with keratitis using more than 1 source of information. The overlapping of *IQCF3* in both the gene-based association study and candidate gene prioritization resulted in a total of 33 hub genes. Functional annotation of the hub genes was performed and transcriptional factors for *IQCF3* and *SOD3* were predicted.

IQ motif containing F3 (*IQCF3*) is located at 3p21.2. The molecular function of IQCF3 is calmodulin binding. *IQCF3* was found in both the gene-based association study and in candidate gene prioritization analysis. Few previous studies have illustrated the relationship between keratitis and *IQCF3*. *IQCF3* appears to be a novel gene underlying keratitis and may provide a potential target for the treatment of keratitis.

Superoxide dismutase 3 (*SOD3*) is located at 4p15.2. *SOD3* encodes extracellular superoxide dismutase. SOD3 is an antioxidant enzyme that catalyzes the dismutation of 2 superoxide radicals into hydrogen peroxide and oxygen, which are thought to play major roles in changes in vascular structure and function in pathophysiology \[[@b28-medscimonit-26-e922710]\]. *SOD3* exists as a copper- and zinc-containing tetramer, and is synthesized containing a signal peptide that directs this enzyme exclusively to extracellular spaces \[[@b29-medscimonit-26-e922710]\]. Reactive oxygen species (ROS)-induced oxidative injury is involved in the pathogenesis of fungal keratitis via the p38 MAPK pathway, and *SOD3* is one of the important molecules in biological oxidation in the cornea \[[@b30-medscimonit-26-e922710]\]. *SOD3* protects the cornea by converting ROS into less-reactive products \[[@b31-medscimonit-26-e922710],[@b32-medscimonit-26-e922710]\]. It appears that *SOD3* could be a therapeutic anti-inflammatory agent due to its strong antioxidant activity and immune-regulatory function \[[@b33-medscimonit-26-e922710]\]. Some researchers have synthesized a SOD derivative to reduce tissue injury in keratitis caused by ROS \[[@b34-medscimonit-26-e922710]\].

C-X3-C motif chemokine receptor 1 (*CX3CR1*) is located at 3p22.2. Protein CX3CR1, encoded by *CX3CR1*, is the sole receptor for fractalkine, which is a transmembrane protein and chemokine involved in the adhesion and migration of leukocytes \[[@b35-medscimonit-26-e922710]\]. It is well-recognized that the peripheral corneal and limbal epithelia contain a resident population of major histocompatibility complex (MHC) class II^+^ intraepithelial dendritic cells (DCs), sometimes called Langerhans cells (LCs). *CX3CR1* was shown to play a role in the normal recruitment of MHC class II^+^ putative DCs into the corneal epithelium \[[@b36-medscimonit-26-e922710]\]. The association between nerves and resident immune cells in normal eyes was reported to be partly mediated by *CX3CR1* signaling in response to central corneal epithelial injury \[[@b37-medscimonit-26-e922710]\]. Other research indicated that accumulation of CX3CR1-positive macrophages can dampen alkali-induced corneal neovascularization by producing antiangiogenic factors such as TSP-1 and ADAMTS-1 \[[@b38-medscimonit-26-e922710]\].

SEC62 Homolog, preprotein translocation factor (*SEC62*), located at 3q26.2, encodes translocation protein SEC62 \[[@b39-medscimonit-26-e922710],[@b40-medscimonit-26-e922710]\]. It participates in post-translational protein translocation into the endoplasmic reticulum (ER) and may also be involved in the backward transport of ER proteins \[[@b40-medscimonit-26-e922710]\]. Dilated ER is considered a general characteristic of keratitis in acute and chronic inflammation \[[@b41-medscimonit-26-e922710]\]. The change becomes more pronounced as the endothelial cells become detached from the Descemet's membrane \[[@b41-medscimonit-26-e922710]\].

Major histocompatibility complex, Class I, B (*HLA-B*), located at 6p21.33, belongs to a gene family called the human leukocyte antigen (HLA) complex class I. HLA is the human version of major histocompatibility complex (MHC). The HLA complex assists the immune system in distinguishing proteins made by foreign invaders, such as viruses and bacteria, from the body's own proteins. The *HLA-B* genes show various polymorphic forms, one of which is *HLA-B5*. *HLA-B5* was found to be related to recurrent herpetic keratitis and recurrent stromal keratitis \[[@b42-medscimonit-26-e922710]\].

Mucin 21 (*MUC21*) is also located at 6p21.33. This gene encodes a large membrane-bound glycoprotein that is a member of the mucin family. Mucins play an important role not only in intracellular signaling, but also in forming protective mucous barriers on epithelial surfaces. The transmembrane mucin MUC21 has been shown to be one of the first lines of defense by mucosal surfaces to limit the access of viruses into the host \[[@b43-medscimonit-26-e922710],[@b44-medscimonit-26-e922710]\]. It has been suggested that transmembrane mucins act as space-filling molecules in glycocalyx and are capable of forming dense network structures that selectively limit viral infection \[[@b45-medscimonit-26-e922710]\]. In the corneal epithelium, the carbohydrate-dependent interactions of galectin-3 with transmembrane mucins help maintain the epithelial barrier \[[@b46-medscimonit-26-e922710]\].

The relationships between keratitis and the other genes identified here have not been determined previously. However, the results of the present study suggest that *SAMD7* is essential for rod photoreceptor cells and is associated with retinitis pigmentosa \[[@b47-medscimonit-26-e922710],[@b48-medscimonit-26-e922710]\]. The downregulation of *PPM1M* significantly inhibits HSV-1 infection, which is associated with herpetic stromal keratitis \[[@b49-medscimonit-26-e922710]\]. A study investigating the molecular mechanisms underlying activation of cell death pathways in human limbal epithelial cell cultures suggested that *HIST4H4* is a significantly upregulated gene during hypothermic storage and that it is involved in a functional network highly associated with cell death, necrosis, and transcription of RNA \[[@b50-medscimonit-26-e922710]\]. These genes were also identified as candidate genes in our study and may be novel susceptible genes underlying keratitis, but this needs further study.

Keratitis is a complex clinical trait that can arise from infectious agents or noninfectious causes. Even though confronted by these pathogens everywhere in daily life, not everyone who is contacted becomes infected, perhaps due to differences in genetic susceptibility to infections. Based on the PPI network and functional annotations of these hub genes, targeted therapies or drug development for keratitis should focus on these genes and pathways.

Although they are potentially related to keratitis, it is unlikely that all of these genes are causally related, as they were identified by statistical association rather than biological validation. In addition, this kind of research is influenced by the structure of the LD, and is generally considered to be indirect gene mapping. The identification of causal genes associated with keratitis still awaits further functional studies.

Conclusions
===========

In conclusion, a total of 34 SNPs from 14 distinct *loci* were identified as associated with keratitis from UKB. Additionally, *IQCF3* and *SOD3* were identified by their p values through gene-based tests on the basis of individual SNP-based tests. Thirty-two candidate genes were then prioritized. The overlapping of *IQCF3* in the gene-based association study and candidate gene prioritization resulted in a total of 33 hub genes. Functional annotation of hub genes was performed and transcriptional factors of *IQCF3* and *SOD3* were predicted. These results, together with the known functional relationship between these genes and keratitis, suggest that *IQCF3* and *SOD3* are candidate genes underlying keratitis. These genes, with good predictive power, may provide a novel approach for selecting high-risk keratitis patients, as well as acting as biomarkers for monitoring, treatments, and drug development.

Supplementary Data
==================

###### 

GO enrichment analysis of hub genes.

  Term          Description             Count in gene set   P value
  ------------- ----------------------- ------------------- ----------
  GO: 0070062   Extracellular exosome   9                   7.00E-03
  GO: 0005516   Calmodulin binding      3                   1.70E-02
  GO: 0031012   Extracellular matrix    3                   4.12E-02

GO -- Gene Ontology.
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![Logarithmic quantile-quantile (QQ) plot and Manhattan plot of individual SNP-based association tests. (**A**) QQ plot of individual SNP-based association tests. The x axis shows the theoretical --log~10~ (p value). The y axis shows the observed --log~10~ (p value). (**B**) Manhattan plot of individual SNP-based association tests. The x axis shows the chromosome numbers. The y axis shows the --log~10~ (p value). The dotted line is the gene-wide significance p value of 5×10^−8^.](medscimonit-26-e922710-g001){#f1-medscimonit-26-e922710}

![QQ plot and Manhattan plot of gene-based association tests. (**A**) QQ plot of gene-based association tests. The x axis shows the theoretical --log~10~ (p value). The y axis shows the observed --log~10~ (p value). (**B**) Manhattan plot of gene-based association tests. The x axis shows the chromosome numbers. The y axis shows the --log~10~ (p value). The dotted line is the gene-wide significance p value of 2.5×10^−6^.](medscimonit-26-e922710-g002){#f2-medscimonit-26-e922710}
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![Functional annotations and predicted signaling pathways. (**A**) The PPI network of the 33 hub genes and their coexpression genes was constructed. Six genes (*SOD3*, *MGP*, *VARS2*, *RPL14*, *HIST4H4*, and *CSNK1G2*) in yellow were considered densely connected nodes in the PPI network. (**B**) Functional enrichment analyses of hub genes were performed by DAVID in a bubble chart.](medscimonit-26-e922710-g004){#f4-medscimonit-26-e922710}

![Transcription factor network of *IQCF3* and *SOD3*. Transcription factor network was predicted in *IQCF3* (**A**) and *SOD3* (**B**). Significant nodes were marked in red in line with these 2 genes.](medscimonit-26-e922710-g005){#f5-medscimonit-26-e922710}

###### 

Main results of the identified novel *loci* in UKB.

  Lead SNP      CHR   POS         Locus      Beta       SE         P              N
  ------------- ----- ----------- ---------- ---------- ---------- -------------- --------
  rs3766652     1     171758370   1q24.3     9.24E-04   1.48E-04   **4.10E-10**   337199
  rs6796010     3     169613751   3q26.2     2.63E-03   4.64E-04   **1.43E-08**   337199
  rs9861402     3     39293844    3p22.2     6.37E-04   1.16E-04   **3.61E-08**   337199
  rs139240291   3     51883928    3p21.2     1.21E-03   2.16E-04   **2.26E-08**   337199
  rs2324638     4     25008851    4p15.2     5.14E-03   6.29E-04   **2.84E-16**   337199
  rs150160025   5     40059390    5p13.1     1.17E-03   1.97E-04   **3.01E-09**   337199
  rs6910636     6     30985793    6p21.33    3.39E-03   5.96E-04   **1.23E-08**   337199
  rs144144964   7     138460918   7q34       1.04E-03   1.86E-04   **2.30E-08**   337199
  rs76229182    7     86504797    7q21.12    1.03E-03   1.79E-04   **9.47E-09**   337199
  rs149409568   8     105903422   8q22.3     1.18E-03   1.70E-04   **4.54E-12**   337199
  rs138303599   10    23672519    10p12.2    7.77E-04   1.38E-04   **2.02E-08**   337199
  rs117460695   12    15958922    12p12.3    1.19E-03   2.12E-04   **2.35E-08**   337199
  rs748230      14    96240891    14q32.13   1.12E-03   2.03E-04   **3.91E-08**   337199
  rs62129468    19    1944342     19p13.3    7.75E-04   1.41E-04   **3.67E-08**   337199

CHR -- chromosome; POS -- genomic position based on GRCH37 genome assembly; Beta -- regression coefficient; SE -- standard error of beta; N -- sample size.

###### 

Main results of the identified novel genes.

  Locus    Gene      Start      Stop       No. SNPs   p Value       Top SNP       Top SNP -- p value
  -------- --------- ---------- ---------- ---------- ------------- ------------- --------------------
  3p21.2   *IQCF3*   51850898   51874874   42         2.00×10^−6^   rs144319860   4.38×10^−7^
  4p15.2   *SOD3*    24787084   24812467   71         2.00×10^−6^   rs800445      2.40×10^−6^

###### 

Prioritized candidate genes at the identified novel *loci*.

  Locus      Lead SNP      Candidate gene
  ---------- ------------- -------------------------------------------------------------------------------
  1q24.3     rs3766652     *METTL13*(N), *PIGC*(S)
  3q26.2     rs6796010     *RP11-379K17.4*(Q), *SEC62*(Q, B), *SAMD7*(N)
  3p22.2     rs9861402     *CX3CR1*(M, N, B), *RPL14*(S)
  3p21.2     rs139240291   *ABHD14A*(Q), *IQCF3*(Q), *RP11-314A5.3*(Q), *PPM1M*(Q), *IQCF2*(N)
  4p15.2     rs2324638     *LGI2*(N), *ANAPC4*(S), *CCDC149*(S)
  5p13.1     rs150160025   *BC026261*(N)
  6p21.33    rs6910636     *HLA-B*(Q, B), *MUC21*(Q, B), *XXbac-BPG248L24.12*(Q), *VARS2*(Q), *MUC22*(N)
  7q34       rs144144964   *ATP6V0A4*(N)
  7q21.12    rs76229182    *KIAA1324L*(N)
  8q22.3     rs149409568   *Mir_584*(N)
  10p12.2    rs138303599   *C10orf67*(N)
  12p12.3    rs117460695   *EPS8*(N), *HIST4H4*(S), *C12orf60*(S), *MGP*(S)
  14q32.13   rs748230      *BX247990*(N)
  19p13.3    rs62129468    *CSNK1G2*(N), *MKNK2*(S)

Genes are prioritized as follow: gene nearest to the lead credible risk variant (CRV) (N); gene containing a mis-sense CRV (M); gene with mRNA levels in association with one or more CRVs (cis-eQTL, Q); gene with biology function with keratitis (B); and gene prioritized by SMR analysis (S).
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